In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This report presents the results of the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008.
In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This report presents the result of the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008.
In July 2014, a panel of two viable isolates of N. meningitidis of the major disease-causing serogroups with three simulated cerebrospinal fluid (non-culture) samples for molecular studies, was sent by UK NEQAS to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
This report presents the results of an external quality assessment carried out in 2014 to test laboratories’ ability to correctly identify strains of Haemophilus influenzae.
The 2013–14 influenza season was mild and dominated by influenza A viruses, with a co-circulation of A(H1N1)pdm09 and A(H3N2) viruses in most countries. Only two countries reported higher syndromic notification rates compared with the previous season.
In September/October 2013, the European Reference Laboratory Network for Human Influenza (ERLI-Net) conducted an external quality assessment (EQA) for the rapid detection of influenza virus, its isolation and culture.
This report presents the results of the influenza virus antiviral (AV) susceptibility external quality assessment (EQA) which was held for European reference laboratories.